✦ LIBER ✦
180 Additional treatment does not improve the survival of locally advanced or metastatic NSCLC patients who responded after two courses of cisplatin (C), vindesin (V), mitomycin (M) chemotherapy
✍ Scribed by Weynants, P.; Humblet, Y.; Jamart, J.; Vindevogel, A.; Nickers, Ph.; Duprez, P.; Symann, M.; Delaunois, L.
- Book ID
- 122360022
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 154 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.